Literature DB >> 17671825

Oxidative stress in patients with COPD and pulmonary hypertension.

Pavol Joppa1, Darina Petrásová, Branislav Stancák, Zuzana Dorková, Ruzena Tkácová.   

Abstract

OBJECTIVE: Oxidative stress plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Oxidant/antioxidant imbalance has also been reported in various forms of pulmonary hypertension. The present study aimed to assess systemic oxidative stress, as reflected by serum malondialdehyde (MDA) concentrations and activities of antioxidant enzymes in erythrocytes [glutathione peroxidase (GPX), superoxide dismutase (SOD) and catalase (CAT)] in patients with and without pulmonary hypertension secondary to COPD. PATIENTS AND METHODS: Seventy-five patients (58 male) with COPD (mean age 65.1 +/- 1.2 years; mean smoking history 35.6 +/- 3.8 pack-years) were studied. Twenty-one healthy non-smokers served as a control group. Pulmonary function was evaluated with body plethysmography; mean and systolic pulmonary artery pressures (Ppa) were assessed with Doppler echocardiography. Serum concentrations of MDA and activities of GPX, SOD and CAT in washed red blood cells were measured using spectrophotometry.
RESULTS: Pulmonary hypertension was present in 28 patients with COPD (systolic Ppa: 46.4 +/- 2.3 mmHg; mean Ppa: 26.0 +/- 1.9 mmHg) and absent in 47 (systolic Ppa: 22.9 +/- 0.8 mmHg; mean Ppa: 13.4 +/- 0.6 mmHg). Compared with the healthy control group, all the patients (with or without pulmonary hypertension) had higher serum MDA concentrations (1.5 +/- 0.1 versus 2.3 +/- 0.1 versus 2.3 +/- 0.1 nmol/mL, ANOVA, P < 0.001) and lower erythrocyte GPX activity (51.3 +/- 3.2 versus 42.2 +/- 2.0 versus 41.3 +/- 2.5 U/g Hb, P = 0.029), whereas SOD (1121.1 +/- 29.0 versus 1032.6 +/- 21.8 versus 1032.7 +/- 36.2 U/g Hb, P = 0.063) and CAT activities (4.9 +/- 0.2 versus 4.6 +/- 0.1 versus 4.7 +/- 0.2 U/g Hb; P= 0.454) were similar. No differences were observed in serum MDA concentrations or activities of GPX, SOD and CAT in erythrocytes between COPD patients with and without pulmonary hypertension.
CONCLUSION: The study demonstrates the presence of oxidative/antioxidative imbalance in the systemic circulation in patients with COPD: compared with healthy subjects, COPD patients had higher serum MDA concentrations and lower GPX activity in erythrocytes. The magnitudes of the increase in MDA and reduction in GPX activity were similar in COPD patients with pulmonary hypertension and in those with normal pulmonary artery pressures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671825     DOI: 10.1007/s00508-007-0819-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  30 in total

1.  Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease.

Authors:  M K Daga; Rashmi Chhabra; Bhavneesh Sharma; T K Mishra
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

2.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

Authors:  P J Currie; J B Seward; K L Chan; D A Fyfe; D J Hagler; D D Mair; G S Reeder; R A Nishimura; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

Review 3.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

Authors:  Daniele Del Rio; Amanda J Stewart; Nicoletta Pellegrini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-08       Impact factor: 4.222

4.  Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.

Authors:  C M Stein; S B Tanner; J A Awad; L J Roberts; J D Morrow
Journal:  Arthritis Rheum       Date:  1996-07

5.  l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension.

Authors:  Debora Cristine Souza-Costa; Talita Zerbini; Ingrid Ferreira Metzger; João Batista Teixeira Rocha; Raquel Fernanda Gerlach; Jose Eduardo Tanus-Santos
Journal:  Nitric Oxide       Date:  2004-12-23       Impact factor: 4.427

6.  Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation.

Authors:  G E Carpagnano; S A Kharitonov; M P Foschino-Barbaro; O Resta; E Gramiccioni; P J Barnes
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

7.  Effects of monocrotaline on endothelial nitric oxide synthase expression and sulfhydryl levels in rat lungs.

Authors:  Rajamma Mathew; Ning Yuan; Louis Rosenfeld; Michael H Gewitz; Ashok Kumar
Journal:  Heart Dis       Date:  2002 May-Jun

8.  Increased lipid peroxidation in patients with pulmonary hypertension.

Authors:  J L Cracowski; C Cracowski; G Bessard; J L Pepin; J Bessard; C Schwebel; F Stanke-Labesque; C Pison
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

Review 9.  Diagnosis and differential assessment of pulmonary arterial hypertension.

Authors:  Robyn J Barst; Michael McGoon; Adam Torbicki; Olivier Sitbon; Michael J Krowka; Horst Olschewski; Sean Gaine
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

10.  Oxidative stress in severe pulmonary hypertension.

Authors:  Rebecca Bowers; Carlyne Cool; Robert C Murphy; Rubin M Tuder; Matthew W Hopken; Sonia C Flores; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

View more
  18 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  Elevated TNFalpha production in whole blood in patients with severe COPD: the potential link to disease severity.

Authors:  Stephan von Haehling; Nicholas S Hopkinson; Michael I Polkey; Margit Niethammer; Stefan D Anker; Sabine Genth-Zotz
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension.

Authors:  Zhang Hong-liang; Luo Qin; Liu Zhi-hong; Zhao Zhi-hui; Xiong Chang-ming; Ni Xin-hai; He Jian-guo; Wei Ying-jie; Zhang Shu
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 4.  Oxidative stress in COPD and its measurement through exhaled breath condensate.

Authors:  Wei Lee; Paul S Thomas
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

Review 5.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

Review 6.  Reactive oxygen species in pulmonary vascular remodeling.

Authors:  Saurabh Aggarwal; Christine M Gross; Shruti Sharma; Jeffrey R Fineman; Stephen M Black
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

7.  Oxidative-stress biomarkers in patients with pulmonary hypertension.

Authors:  Graziela S Reis; Viviane S Augusto; Ana Paula C Silveira; Alceu A Jordão; José Baddini-Martinez; Omero Poli Neto; Alfredo José Rodrigues; Paulo Roberto B Evora
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

8.  Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD.

Authors:  Karin Vonbank; Georg Christian Funk; Beatrice Marzluf; Bernhard Burian; Rolf Ziesche; Leopold Stiebellehner; Ventzislav Petkov; Paul Haber
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients.

Authors:  Md Ismail; Md Faruk Hossain; Arifur Rahman Tanu; Hossain Uddin Shekhar
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

10.  Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats.

Authors:  Sadollah Mohammadi; Moslem Najafi; Hossein Hamzeiy; Nasrin Maleki-Dizaji; Masoud Pezeshkian; Homayon Sadeghi-Bazargani; Masoud Darabi; Sara Mostafalou; Shahab Bohlooli; Alireza Garjani
Journal:  Adv Pharmacol Sci       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.